Cargando…

Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer

AIM: To assess the value of bone scintigraphy and (18)F-fluorocholine PET/computed tomography (CT) in predicting outcome in patients with prostate cancer and bone metastases treated with (223)radium. MATERIALS & METHODS: Retrospective analysis of 48 patients that underwent (223)radium therapy. E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klain, Michele, Gaudieri, Valeria, Petretta, Mario, Zampella, Emilia, Storto, Giovanni, Nappi, Carmela, Buonerba, Carlo, Crocetto, Felice, Gallicchio, Rosj, Volpe, Fabio, Pace, Leonardo, Schlumberger, Martin, Cuocolo, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288237/ https://www.ncbi.nlm.nih.gov/pubmed/34295537 http://dx.doi.org/10.2144/fsoa-2021-0053

Ejemplares similares

Incremental Value of Sestamibi SPECT/CT Over Dual-Phase Planar Scintigraphy in Patients With Primary Hyperparathyroidism and Inconclusive Ultrasound
por: Assante, Roberta, et al.
Publicado: (2019)

Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223
por: Roviello, Giandomenico, et al.
Publicado: (2018)

Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer
por: Zampella, Emilia, et al.
Publicado: (2023)

Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer
por: Piscopo, Leandra, et al.
Publicado: (2022)

Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis
por: Klain, Michele, et al.
Publicado: (2021)

Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis
por: Piscopo, Leandra, et al.
Publicado: (2023)

Hyperfunctioning parathyroid gland and skeletal involvement on [(18)F]fluorocholine PET/CT: one look with two views
por: Nappi, Carmela, et al.
Publicado: (2022)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease
por: Nappi, Carmela, et al.
Publicado: (2020)

Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study
por: Piscopo, Leandra, et al.
Publicado: (2022)

Advances in Functional Imaging of Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Prognostic value of heart rate reserve in patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging
por: Nappi, Carmela, et al.
Publicado: (2021)

Interim and end-treatment (18)F-Fluorocholine PET/CT and bone scan in prostate cancer patients treated with Radium 223 dichloride
por: García Vicente, Ana María, et al.
Publicado: (2021)

Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging
por: Assante, Roberta, et al.
Publicado: (2021)

Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives
por: Volpe, Fabio, et al.
Publicado: (2023)

Cardiac hybrid imaging: novel tracers for novel targets
por: Ponsiglione, Andrea, et al.
Publicado: (2021)

Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease
por: Gaudieri, Valeria, et al.
Publicado: (2021)

Prevalence and Severity of Myocardial Perfusion Imaging Abnormalities in Inmate Subjects
por: Assante, Roberta, et al.
Publicado: (2015)

Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors
por: Gallicchio, Rosj, et al.
Publicado: (2023)

A Comparison among Different Machine Learning Pretest Approaches to Predict Stress-Induced Ischemia at PET/CT Myocardial Perfusion Imaging
por: Megna, Rosario, et al.
Publicado: (2021)

Prognostic value of myocardial perfusion imaging by cadmium zinc telluride single-photon emission computed tomography in patients with suspected or known coronary artery disease: a systematic review and meta-analysis
por: Assante, Roberta, et al.
Publicado: (2023)

Age-Specific Cardiovascular Risk Factors for Major Adverse Cardiac Events in Patients Undergoing Myocardial Perfusion Imaging
por: Megna, Rosario, et al.
Publicado: (2023)

External validation and update of the J-ACCESS model in an Italian cohort of patients undergoing stress myocardial perfusion imaging
por: Petretta, Mario, et al.
Publicado: (2023)

Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say
por: Mannarino, Teresa, et al.
Publicado: (2023)

Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium
por: Nappi, Carmela, et al.
Publicado: (2023)

Simultaneous assessment of myocardial perfusion and adrenergic innervation in patients with heart failure by low-dose dual-isotope CZT SPECT imaging
por: Assante, Roberta, et al.
Publicado: (2022)

Pitfalls in Risk Stratification: The Case of Acute Pulmonary Embolism
por: Petretta, Mario, et al.
Publicado: (2023)

Radium-223 and concomitant therapies: prospects and prudence
por: Yeku, Oladapo, et al.
Publicado: (2016)

Radium 223 dichloride for prostate cancer treatment
por: Deshayes, Emmanuel, et al.
Publicado: (2017)

Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics
por: Kairemo, Kalevi, et al.
Publicado: (2015)

Behind Traditional Semi-quantitative Scores of Myocardial Perfusion Imaging: An Eye on Niche Parameters
por: Nappi, Carmela, et al.
Publicado: (2019)

Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge
por: Klain, Michele, et al.
Publicado: (2020)

Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study
por: Vija Racaru, Lavinia, et al.
Publicado: (2018)

Regional myocardial perfusion imaging in predicting vessel-related outcome: interplay between the perfusion results and angiographic findings
por: Mannarino, Teresa, et al.
Publicado: (2022)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Radium-223 for the treatment of castration-resistant prostate cancer
por: El-Amm, Joelle, et al.
Publicado: (2015)

Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA
por: Sartor, Oliver, et al.
Publicado: (2016)

Current approaches to incorporation of radium-223 in clinical practice
por: Parker, Chris, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6bk9aact29v9jq5sjt6628sii0